Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Forzinity Chronology: Stealth’s Barth Syndrome Drug Bounced Around US FDA Review Divisions
Nov 04 2025
•
By
Sue Sutter
Stealth's Forzinity had a complicated regulatory history.
(Nancy Pham)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Drug Review Profiles
More from United States